(1)
Prasasty, V. D.; Yulandi, A. STRUCTURE-BASED DESIGN OF NOVEL RILPIVIRINE ANALOGUES AS HIV-1 NON-NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITORS THROUGH QSPR AND MOLECULAR DOCKING. Int J Pharm Pharm Sci 2015, 7, 340-345.